Federal Capture Intelligence

Top VA in-vitro diagnostic substance manufacturing contractors (NAICS 325413)

Contract actions: October 1, 2021 – September 10, 2026 Updated September 11, 2026 Department of Veterans Affairs agency guide NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
Latest 12 months
$106.5M
Net obligations · Down $9.6M vs. $116.1M preceding
Prime contractors
79
With positive obligations in the latest 12 months

Research the VA federal contracting market for in-vitro diagnostic substance manufacturing under NAICS 325413. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, and contract types, competition, and procurement methods.

Contract obligation trends for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs

Federal records show $777.8M in net obligations across 3,854 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Sep 10, 2026. This market accounts for 0.23% of $339.1B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 8.3% from $116.1M to $106.5M. 10 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $104.1M versus $107.2M through the same date in FY25 (−2.9%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$284.9M1,711Complete
FY2023$201.9M1,647Complete
FY2024$77.3M1,831Complete
FY2025$109.6M1,626Complete
FY2026$104.1M1,588YTD through Sep 10, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$777.8M
3,854 awards · 171 prime contractors
Latest 12-month movement
−8.3%
$106.5M vs. $116.1M
Leading eight prime share
77.9%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
0.23% of $339.1B in agency-wide net obligations.
Set-aside share when reported
16.9% of 1,514 awards with reported set-aside status.
Set-aside reporting
256 set aside · 1,258 no set-aside · 2,340 not reported

What changed in the last 12 months?

Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.

Competitive shifts

IMMUCOR INC fell the most in the contractor rankings
#9→#66Down 57 places
The contractor accounts for 0.040% of positive obligations across 21 reported actions.
CEPHEID lost the most market share
26.9%→22.1%−4.8 percentage points
The contractor now ranks #2 by positive obligations, based on 190 reported actions.
ROCHE DIAGNOSTICS CORPORATION had the largest increase in reported obligations
$10.7M→$13.2M+$2.6M
The contractor now ranks #3 by positive obligations and accounts for 12.2% of positive obligations, based on 200 reported actions.

Buyer demand

Reported obligations through 589 KAN WESTERN ORBIT decreased
$6.8M→$505K−$6.3M
Latest-period activity spans 32 awards across 14 prime contractors.
Reported obligations through 241-NETWORK CONTRACT OFFICE 01 (36C241) increased
$3.6M→$6.6M+$3.0M
Latest-period activity spans 42 awards across 17 prime contractors.

Market structure

Top-five contractor share increased
64.6%→72.5%+7.9 percentage points
Contractors outside the top five now account for 27.5% of positive obligations.
View 1 additional material change

Competitive shifts

BIOMERIEUX INC gained the most market share
23.74%→27.07%+3.3 percentage points
The contractor now ranks #1 by positive obligations, based on 260 reported actions.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.

6.3% of positive obligations were attributed to 691-VA GREATER LA HLTHCR SYS(00691). That represents $6.8M, up $19K from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. 691-VA GREATER LA HLTHCR SYS(00691)6.3% · $6.8M · up $19K
  2. 241-NETWORK CONTRACT OFFICE 01 (36C241)6.0% · $6.6M · up $3.0M
  3. 261-NETWORK CONTRACT OFFICE 21 (36C261)5.9% · $6.5M · up $2.2M
  4. 248-NETWORK CONTRACT OFFICE 8 (36C248)5.8% · $6.3M · up $1.4M
  5. 644-PHOENIX (00644)5.1% · $5.5M · up $2.5M
  6. All other reported offices71.0% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    691-VA GREATER LA HLTHCR SYS(00691)

    #1Up 1 from #2

    Latest 12 months

    $6.8M

    6.3% of positive obligations

    Versus preceding 12 months

    +$19K

    22 active prime contractors · 45 awards

    View office comparison and evidence

    Reported obligations increased 0.3% from $6.8M to $6.8M. The office’s share of positive obligations moved from 5.7% to 6.3%, a change of +0.6 percentage points.

    The latest period contains 63 actions across 45 awards and 7 newly active prime contractors. The preceding period contained 17 active prime contractors and 28 awards.

  2. Reported funding office

    241-NETWORK CONTRACT OFFICE 01 (36C241)

    #2Up 7 from #9

    Latest 12 months

    $6.6M

    6.0% of positive obligations

    Versus preceding 12 months

    +$3.0M

    17 active prime contractors · 42 awards

    View office comparison and evidence

    Reported obligations increased 82.5% from $3.6M to $6.6M. The office’s share of positive obligations moved from 3.0% to 6.0%, a change of +3.0 percentage points.

    The latest period contains 53 actions across 42 awards and 8 newly active prime contractors. The preceding period contained 14 active prime contractors and 30 awards.

    Leading award-level changes

  3. Reported funding office

    261-NETWORK CONTRACT OFFICE 21 (36C261)

    #3Up 2 from #5

    Latest 12 months

    $6.5M

    5.9% of positive obligations

    Versus preceding 12 months

    +$2.2M

    5 active prime contractors · 25 awards

    View office comparison and evidence

    Reported obligations increased 52.7% from $4.2M to $6.5M. The office’s share of positive obligations moved from 3.5% to 5.9%, a change of +2.4 percentage points.

    The latest period contains 32 actions across 25 awards and 1 newly active prime contractor. The preceding period contained 9 active prime contractors and 38 awards.

  4. Reported funding office

    248-NETWORK CONTRACT OFFICE 8 (36C248)

    #4Rank unchanged

    Latest 12 months

    $6.3M

    5.8% of positive obligations

    Versus preceding 12 months

    +$1.4M

    4 active prime contractors · 14 awards

    View office comparison and evidence

    Reported obligations increased 30.1% from $4.8M to $6.3M. The office’s share of positive obligations moved from 4.0% to 5.8%, a change of +1.7 percentage points.

    The latest period contains 18 actions across 14 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 15 awards.

  5. Reported funding office

    644-PHOENIX (00644)

    #5Up 5 from #10

    Latest 12 months

    $5.5M

    5.1% of positive obligations

    Versus preceding 12 months

    +$2.5M

    4 active prime contractors · 19 awards

    View office comparison and evidence

    Reported obligations increased 84.6% from $3.0M to $5.5M. The office’s share of positive obligations moved from 2.5% to 5.1%, a change of +2.6 percentage points.

    The latest period contains 29 actions across 19 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 10 awards.

  6. Reported funding office

    600-VA LONG BEACH HLTCAR SYS(00600)

    #6Rank unchanged

    Latest 12 months

    $5.1M

    4.7% of positive obligations

    Versus preceding 12 months

    +$1.1M

    7 active prime contractors · 10 awards

    View office comparison and evidence

    Reported obligations increased 27.4% from $4.0M to $5.1M. The office’s share of positive obligations moved from 3.4% to 4.7%, a change of +1.3 percentage points.

    The latest period contains 14 actions across 10 awards and 1 newly active prime contractor. The preceding period contained 8 active prime contractors and 12 awards.

  7. Reported funding office

    674-TEMPLE (00674)

    #7Up 11 from #18

    Latest 12 months

    $3.5M

    3.2% of positive obligations

    Versus preceding 12 months

    +$1.7M

    11 active prime contractors · 19 awards

    View office comparison and evidence

    Reported obligations increased 97.8% from $1.7M to $3.5M. The office’s share of positive obligations moved from 1.5% to 3.2%, a change of +1.7 percentage points.

    The latest period contains 35 actions across 19 awards and 2 newly active prime contractors. The preceding period contained 10 active prime contractors and 15 awards.

  8. Reported funding office

    664-SAN DIEGO HEALTHCARE SYS(00664)

    #8Down 5 from #3

    Latest 12 months

    $3.0M

    2.8% of positive obligations

    Versus preceding 12 months

    −$2.4M

    10 active prime contractors · 21 awards

    View office comparison and evidence

    Reported obligations decreased 44.2% from $5.4M to $3.0M. The office’s share of positive obligations moved from 4.5% to 2.8%, a change of −1.8 percentage points.

    The latest period contains 34 actions across 21 awards and 3 newly active prime contractors. The preceding period contained 9 active prime contractors and 14 awards.

  9. Reported funding office

    549-DALLAS (00549)

    #9Up 5 from #14

    Latest 12 months

    $3.0M

    2.7% of positive obligations

    Versus preceding 12 months

    +$454K

    18 active prime contractors · 31 awards

    View office comparison and evidence

    Reported obligations increased 18.1% from $2.5M to $3.0M. The office’s share of positive obligations moved from 2.1% to 2.7%, a change of +0.6 percentage points.

    The latest period contains 39 actions across 31 awards and 3 newly active prime contractors. The preceding period contained 15 active prime contractors and 26 awards.

  10. Reported funding office

    675-ORLANDO (00675)(36C675)

    #10Up 2 from #12

    Latest 12 months

    $2.7M

    2.5% of positive obligations

    Versus preceding 12 months

    −$153K

    2 active prime contractors · 4 awards

    View office comparison and evidence

    Reported obligations decreased 5.4% from $2.8M to $2.7M. The office’s share of positive obligations moved from 2.4% to 2.5%, a change of +0.1 percentage points.

    The latest period contains 4 actions across 4 awards. The preceding period contained 2 active prime contractors and 4 awards.

  11. Reported funding office

    VETERANS HEALTH ADMINISTRATION

    #26Down 19 from #7

    Latest 12 months

    $1.2M

    1.1% of positive obligations

    Versus preceding 12 months

    −$2.8M

    8 active prime contractors · 28 awards

    View office comparison and evidence

    Reported obligations decreased 69.2% from $4.0M to $1.2M. The office’s share of positive obligations moved from 3.3% to 1.1%, a change of −2.2 percentage points.

    The latest period contains 47 actions across 28 awards. The preceding period contained 10 active prime contractors and 24 awards.

  12. Reported funding office

    589 KAN WESTERN ORBIT

    #48Down 47 from #1

    Latest 12 months

    $505K

    0.46% of positive obligations

    Versus preceding 12 months

    −$6.3M

    14 active prime contractors · 32 awards

    View office comparison and evidence

    Reported obligations decreased 92.6% from $6.8M to $505K. The office’s share of positive obligations moved from 5.7% to 0.46%, a change of −5.2 percentage points.

    The latest period contains 56 actions across 32 awards and 1 newly active prime contractor. The preceding period contained 17 active prime contractors and 32 awards.

    Leading award-level changes

  13. Reported funding office

    523-BOSTON (00523)(36C523)

    #52Down 41 from #11

    Latest 12 months

    $449K

    0.41% of positive obligations

    Versus preceding 12 months

    −$2.5M

    11 active prime contractors · 21 awards

    View office comparison and evidence

    Reported obligations decreased 84.6% from $2.9M to $449K. The office’s share of positive obligations moved from 2.4% to 0.41%, a change of −2.0 percentage points.

    The latest period contains 22 actions across 21 awards. The preceding period contained 15 active prime contractors and 27 awards.

  14. Reported funding office

    244-NETWORK CONTRACT OFFICE 4 (36C244)

    No positive-obligation rank

    Latest 12 months

    −$209K

    0% of positive obligations

    Versus preceding 12 months

    −$3.9M

    3 active prime contractors · 20 awards

    View office comparison and evidence

    Reported obligations moved from $3.7M in net obligations to $209K in net deobligations. The office’s share of positive obligations moved from 3.1% to 0%, a change of −3.1 percentage points.

    The latest period contains 28 actions across 20 awards and 1 newly active prime contractor. The preceding period contained 4 active prime contractors and 27 awards.

Contract types, competition, and procurement methods

From Sep 11, 2025 through Sep 10, 2026, 720 awards had positive obligations totaling $134.8M. Simplified Acquisition was the leading reported procedure, accounting for 35.3% of positive obligations. Awards with a reported parent IDV accounted for 77.9%.

Leading award type
43.4%
Delivery Order
Leading reported procedure
35.3%
Simplified Acquisition
Reported parent IDV
77.9%
of positive obligations had a reported parent IDV
Median reported offers
1
348 of 720 awards reported offers

Buying method changes

Compared with Sep 11, 2024–Sep 10, 2025. Based on 720 current awards and 795 preceding awards with positive net obligations.

Simplified Acquisition obligation share
35.3%
Down from 46.9% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325413 peer median, parent-IDV obligation share is 17.2 percentage points higher, reported full-and-open obligation share is 16.7 percentage points higher, delivery-order obligation share is 14.8 percentage points higher, and median positive award obligations are 72.0% higher.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share77.9%60.7%+17.2 pts
Reported full-and-open obligation share26.5%9.8%+16.7 pts
Delivery-order obligation share43.4%28.6%+14.8 pts
Median positive award obligations$71K$41K+72.0%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)337$58.5M43.4%
BPA Call(A)236$46.6M34.5%
Purchase Order(B)137$28.0M20.8%
Definitive Contract(D)10$1.7M1.3%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)256$49.2M36.5%
BPA(E)236$46.6M34.5%
FSS(C)81$9.4M6.9%
Not reported147$29.7M22.1%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)468$95.2M70.6%
Multiple Award(M)105$9.9M7.4%
Not reported147$29.7M22.1%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Simplified Acquisition(SP1)262$47.6M35.3%
Only One Source(SSS)130$32.2M23.9%
Subject to Multiple Award Fair Opportunity(MAFO)194$27.9M20.7%
Sss(ONLY ONE SOURCE)22$8.4M6.2%
Negotiated Proposal/Quote(NP)28$8.2M6.1%
Sp1(SIMPLIFIED ACQUISITION)49$6.2M4.6%
Other reported values35$4.4M3.3%

Extent competed

Reported valueAwardsPositive obligationsShare
Full and Open Competition(A)218$35.8M26.5%
Not Competed(C)128$31.8M23.6%
Not Competed Under SAP(G)101$24.0M17.8%
Competed Under SAP(F)163$23.6M17.5%
C(NOT COMPETED)22$8.4M6.2%
F(COMPETED UNDER SAP)37$4.5M3.4%
Other reported values51$6.7M5.0%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Fair Opportunity Given(FAIR)128$15.6M11.5%
Only One Source - Other(ONE)90$15.1M11.2%
Other Statutory Authority(OSA)3$340K0.25%
Follow-on Action Following Competitive Initial Action(FOO)3$185K0.14%
Competitive Set Aside(CSA)3$88K0.070%
Sole Source(SS)1$38K0.030%
Not reported492$103.5M76.8%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Only One Source-Other (FAR 6.302-1 Other)(ONE)129$30.4M22.6%
SAP Non-Competition (FAR 13)(SP2)95$19.9M14.8%
Urgency (FAR 6.302-2)(URG)11$8.9M6.6%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)20$6.1M4.5%
Brand Name Description (FAR 6.302-1(C))(BND)6$550K0.41%
Unique Source (FAR 6.302-1(B)(1))(UNQ)3$275K0.20%
Other reported values1$54K0.040%
Not reported455$68.6M50.9%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)614$115.9M86.0%
J(FIRM FIXED PRICE)106$18.9M14.0%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)465$89.2M66.1%
Laboratory Equipment and Supplies(6640)133$24.5M18.2%
Reference Laboratory Testing(Q301)28$11.6M8.6%
Medical and Surgical Instruments, Equipment, and Supplies(6515)38$5.1M3.8%
Chemical Analysis Instruments(6630)16$2.8M2.1%
Optical Instruments, Test Equipment, Components and Accessories(6650)5$467K0.35%
Other reported values35$1.2M0.86%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Department of Veterans Affairs(3600)720$134.8M100.0%

Awarding offices

Reported valueAwardsPositive obligationsShare
262-Network Contract Office 22 (36c262)(36C262)104$28.4M21.0%
248-Network Contract Office 8 (36c248)(36C248)29$12.7M9.4%
257-Network Contract Office 17 (36c257)(36C257)66$12.1M9.0%
246-Network Contracting Office 6 (36c246)(36C246)70$10.1M7.5%
241-Network Contract Office 01 (36c241)(36C241)52$9.0M6.7%
249-Network Contract Office 9 (36c249)(36C249)34$7.8M5.8%
Other reported values365$54.8M40.7%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
36C24825D0014(3600)7$6.3M4.7%
36C24626D0001(3600)15$4.5M3.3%
36F79724D0020(3600)14$3.3M2.5%
36C26225A0004(3600)1$2.8M2.1%
36C25223D0075(3600)8$2.8M2.0%
36C25524A0028(3600)2$2.6M1.9%
36C25225A0002(3600)8$2.5M1.8%
36C24123A0017(3600)1$2.4M1.8%
Other reported values517$78.0M57.9%
Not reported147$29.7M22.1%

Offers, award size, and timing

Median reported offers
1 median
348 reported · 372 not reported
Positive award obligations
$71K median
$28K–$202K middle 50%
Reported performance period
364 days (~12 months) median
719 reported · 1 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
10 of 79prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
27.1%of positive obligations in the last 12 months
Leading four prime contractors
69.2%of positive obligations in the last 12 months
Leading eight prime contractors
77.9%of positive obligations in the last 12 months

Based on $108.0M in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $29.2M

    27.1%

    Dollar movement

    +$1.3M

    vs. prior 12 months

    Last 12mo awards

    202 awards

    260 actions

    Historical and award details for BIOMERIEUX INC
    Obligations: prior → latest
    $27.9M → $29.2M
    +4.7%
    Share: prior → latest
    23.7% → 27.1%
    +3.3 percentage points
    All-period obligations
    $76.7M
    9.8% of all-period positive obligations · 388 awards
    Recorded activity
    Since Oct 1, 2021
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside2634
    Not reported176125
    Reported small business24
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $23.9M

    22.1%

    Dollar movement

    −$7.8M

    vs. prior 12 months

    Last 12mo awards

    112 awards

    190 actions

    Historical and award details for CEPHEID
    Obligations: prior → latest
    $31.7M → $23.9M
    −24.6%
    Share: prior → latest
    26.9% → 22.1%
    −4.8 percentage points
    All-period obligations
    $285.5M
    36.6% of all-period positive obligations · 346 awards
    Recorded activity
    Since Oct 1, 2021
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside2623
    Not reported86104
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $13.2M

    12.2%

    Dollar movement

    +$2.6M

    vs. prior 12 months

    Last 12mo awards

    150 awards

    200 actions

    Historical and award details for ROCHE DIAGNOSTICS CORPORATION
    Obligations: prior → latest
    $10.7M → $13.2M
    +24.1%
    Share: prior → latest
    9.1% → 12.2%
    +3.2 percentage points
    All-period obligations
    $51.1M
    6.5% of all-period positive obligations · 444 awards
    Recorded activity
    Since Oct 1, 2021
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside4845
    Not reported102114
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $8.3M

    7.7%

    Dollar movement

    +$8.3M

    vs. prior 12 months

    Last 12mo awards

    8 awards

    21 actions

    Historical and award details for QUEST DIAGNOSTICS INCORPORATED
    Obligations: prior → latest
    $0 → $8.3M
    Not comparable
    Share: prior → latest
    0% → 7.7%
    +7.7 percentage points
    All-period obligations
    $8.4M
    1.1% of all-period positive obligations · 9 awards
    Recorded activity
    Since Feb 1, 2023
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside80
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $3.6M

    3.3%

    Dollar movement

    +$988K

    vs. prior 12 months

    Last 12mo awards

    47 awards

    77 actions

    Historical and award details for FISHER SCIENTIFIC COMPANY L.L.C.
    Obligations: prior → latest
    $2.6M → $3.6M
    +38.4%
    Share: prior → latest
    2.2% → 3.3%
    +1.1 percentage points
    All-period obligations
    $13.8M
    1.8% of all-period positive obligations · 129 awards
    Recorded activity
    Since Oct 1, 2021
    through Sep 1, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside1210
    Not reported3538
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $2.0M

    1.9%

    Dollar movement

    +$786K

    vs. prior 12 months

    Last 12mo awards

    94 awards

    129 actions

    Historical and award details for WERFEN USA LLC
    Obligations: prior → latest
    $1.3M → $2.0M
    +62.4%
    Share: prior → latest
    1.1% → 1.9%
    +0.8 percentage points
    All-period obligations
    $5.0M
    0.65% of all-period positive obligations · 132 awards
    Recorded activity
    Since Oct 27, 2021
    through Sep 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside155
    Not reported7952
    Reported small business1714
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $2.0M

    1.8%

    Dollar movement

    −$747K

    vs. prior 12 months

    Last 12mo awards

    46 awards

    56 actions

    Historical and award details for ABBOTT LABORATORIES INC.
    Obligations: prior → latest
    $2.7M → $2.0M
    −27.4%
    Share: prior → latest
    2.3% → 1.8%
    −0.5 percentage points
    All-period obligations
    $8.6M
    1.1% of all-period positive obligations · 165 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 27, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside53
    Not reported4158
    Reported small business00
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $1.9M

    1.8%

    Dollar movement

    +$360K

    vs. prior 12 months

    Last 12mo awards

    16 awards

    21 actions

    Historical and award details for BECTON, DICKINSON AND COMPANY
    Obligations: prior → latest
    $1.5M → $1.9M
    +23.6%
    Share: prior → latest
    1.3% → 1.8%
    +0.5 percentage points
    All-period obligations
    $4.4M
    0.56% of all-period positive obligations · 43 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 23, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside119
    Not reported53
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $1.7M

    1.6%

    Dollar movement

    −$442K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    3 actions

    Historical and award details for ABBOTT LABORATORIES INC.
    Obligations: prior → latest
    $2.1M → $1.7M
    −20.9%
    Share: prior → latest
    1.8% → 1.6%
    −0.3 percentage points
    All-period obligations
    $335K
    0.040% of all-period positive obligations · 28 awards
    Recorded activity
    Since Oct 1, 2021
    through Jul 24, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported34
    Reported small business00
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $1.4M

    1.3%

    Dollar movement

    +$636K

    vs. prior 12 months

    Last 12mo awards

    23 awards

    31 actions

    Historical and award details for BECKMAN COULTER, INC
    Obligations: prior → latest
    $796K → $1.4M
    +80.0%
    Share: prior → latest
    0.68% → 1.3%
    +0.7 percentage points
    All-period obligations
    $7.5M
    0.96% of all-period positive obligations · 83 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 17, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside1622
    Not reported78
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $1.3M

    1.2%

    Dollar movement

    +$359K

    vs. prior 12 months

    Last 12mo awards

    15 awards

    21 actions

    Historical and award details for BINDING SITE, INC., THE
    Obligations: prior → latest
    $977K → $1.3M
    +36.8%
    Share: prior → latest
    0.83% → 1.2%
    +0.4 percentage points
    All-period obligations
    $5.1M
    0.65% of all-period positive obligations · 34 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside01
    Reported no set-aside108
    Not reported56
    Reported small business1414
    All-period set-aside types
    • 1 · Total small business
  12. #12

    Last 12mo obligations

    $1.3M

    1.2%

    Dollar movement

    −$172K

    vs. prior 12 months

    Last 12mo awards

    17 awards

    21 actions

    Historical and award details for GOVERNMENT SCIENTIFIC SOURCE INC
    Obligations: prior → latest
    $1.4M → $1.3M
    −12.1%
    Share: prior → latest
    1.2% → 1.2%
    −0.1 percentage points
    All-period obligations
    $6.3M
    0.81% of all-period positive obligations · 71 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside10
    Reported no set-aside85
    Not reported87
    Reported small business1712
    All-period set-aside types
    • 5 · Total small business
    • 1 · Partial small business
    • 1 · Veteran set-aside
  13. #13

    Last 12mo obligations

    $1.2M

    1.1%

    Dollar movement

    +$352K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for ONE LAMBDA, INC.
    Obligations: prior → latest
    $847K → $1.2M
    +41.5%
    Share: prior → latest
    0.72% → 1.1%
    +0.4 percentage points
    All-period obligations
    $3.2M
    0.41% of all-period positive obligations · 7 awards
    Recorded activity
    Since Mar 2, 2022
    through May 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported22
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $1.2M

    1.1%

    Dollar movement

    −$312K

    vs. prior 12 months

    Last 12mo awards

    14 awards

    18 actions

    Historical and award details for QIAGEN, LLC
    Obligations: prior → latest
    $1.5M → $1.2M
    −21.0%
    Share: prior → latest
    1.3% → 1.1%
    −0.2 percentage points
    All-period obligations
    $4.6M
    0.59% of all-period positive obligations · 33 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside1211
    Not reported22
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $1.1M

    0.97%

    Dollar movement

    −$2.0M

    vs. prior 12 months

    Last 12mo awards

    20 awards

    29 actions

    Historical and award details for ABBOTT MOLECULAR INC.
    Obligations: prior → latest
    $3.0M → $1.1M
    −65.0%
    Share: prior → latest
    2.6% → 0.97%
    −1.6 percentage points
    All-period obligations
    $16.4M
    2.1% of all-period positive obligations · 83 awards
    Recorded activity
    Since Oct 1, 2021
    through Aug 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside67
    Not reported1417
    Reported small business00
    All-period set-aside types

    None reported.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Deobligation

This action

−$1.4M

ABBOTT MOLECULAR INC.

DEPT OF VETERANS AFFAIRS

DE-OBLIGATION OF EXCESS FUNDS

Why it stands out

This award recorded a material contraction.

The action removed $1.4M. A deobligation does not by itself show lower requirement demand.

Award net obligations
$815K
Share of 12-month positive obligations
1.3%
Supporting data
Prime contractor
#15 · 0.97% share
down 11 ranks · −1.6 percentage points · $2.0M net decline; action accounted for 70.4%
Funding office
0% attributed share
−1.7 percentage points · $2.1M net decline; action accounted for 65.6%
PIID 36C24225N0080 · Mod P00001
Base award

This action

+$2.4M

CEPHEID

241-NETWORK CONTRACT OFFICE 01 (36C241)

MICROBIOLOGY REAGENTS & CONSUMABLES ADD CLAUSE 852.222-71 - COMPLIANCE WITH EXECUTIVE ORDER 13899

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 2.2% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $7.8M overall.

Award net obligations
$2.4M
Share of 12-month positive obligations
2.2%
Supporting data
Prime contractor
#2 · 22.1% share
$7.8M net decline despite this positive action
Funding office
#2 · 6.0% attributed share
up 7 ranks · +3.0 percentage points · $3.0M net increase; action accounted for 79.1%
Related:Funding office gain
PIID 36C24126N0005
Base award

This action

+$2.0M

CEPHEID

644-PHOENIX (00644)

COVID REAGENTS

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 1.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $7.8M overall.

Award net obligations
$2.0M
Share of 12-month positive obligations
1.8%
Supporting data
Prime contractor
#2 · 22.1% share
$7.8M net decline despite this positive action
Funding office
#5 · 5.1% attributed share
up 5 ranks · +2.6 percentage points · $2.5M net increase; action accounted for 78.5%
PIID 36C26226P0733
Base award

This action

+$785K

FISHER SCIENTIFIC COMPANY L.L.C.

691-VA GREATER LA HLTHCR SYS(00691)

REAGENTS

Why it stands out

The contractor and funding office both climbed their market rankings.

Both rank changes are shown in the supporting movement data.

Award net obligations
$1.1M
Share of 12-month positive obligations
0.73%
Supporting data
Prime contractor
#5 · 3.3% share
up 1 rank · +1.1 percentage points · $988K net increase; action accounted for 79.5%
PIID 36C26226P0487
Base award

This action

+$1.2M

ROCHE DIAGNOSTICS CORPORATION

648-PORTLAND (00648)

CHEMISTRY IMMUNOCHEMISTRY INSTRUMENTATION REAGENTS, CONSUMABLES AND SUPPLIES FOR VA PORTLAND HEALTH CARE SYSTEM.

Why it stands out

The funding office climbed 5 positions in attributed spending.

It now ranks #16 in attributed spending.

Award net obligations
$700K
Share of 12-month positive obligations
1.1%
Supporting data
Prime contractor
#3 · 12.2% share
+3.2 percentage points · $2.6M net increase; action accounted for 46.7%
Related:Largest contractor gain
PIID 36C26026N0117
Deobligation

This action

−$637K

HOLOGIC, INC.

626-NASHVILLE (00626)

MICROBIOLOGY TEST ASSAY, KITS, SUPPLIES CLIN CORRECTION DECREASE FOR FINAL OBLIGATION

Why it stands out

This award recorded a material contraction.

The action removed $637K. A deobligation does not by itself show lower requirement demand.

Award net obligations
$203K
Share of 12-month positive obligations
0.59%
Supporting data
Prime contractor
#65 · 0.050% share
down 49 ranks · −1.0 percentage points · $1.2M net decline; action accounted for 53.6%
PIID 36C24925N0069 · Mod P00001
View recent award activity by date (10)
  1. 10X GENOMICS, INC.Modification · PIID 36C24225P1431
    Action+$141K
    Award net obligations$475K
  2. BIOMERIEUX INCModification · PIID 36C24926N0572
    Action+$30K
    Award net obligations$64K
  3. HOLOGIC SALES AND SERVICE, LLCBase award · PIID 36C25926N0396
    Action+$30K
    Award net obligations$30K
  4. MESO SCALE DIAGNOSTICS LLCBase award · PIID 36C26026P0773
    Action+$25K
    Award net obligations$25K
  5. QUEST DIAGNOSTICS INCORPORATEDModification · PIID 36C26226P0031
    Action+$20K
    Award net obligations$447K
  6. BRANCH MEDICAL LLCModification · PIID 36C26225P0387
    Action+$2K
    Award net obligations$119K
  7. CEPHEIDDeobligation · PIID 36C24425N1218
    Action−$24
    Award net obligations$293K
  8. ROCHE DIAGNOSTICS CORPORATIONDeobligation · PIID 36C24225N0476
    Action−$17K
    Award net obligations$260K
  9. WERFEN USA LLCBase award · PIID 36C24126N0913
    Action+$16K
    Award net obligations$16K
  10. WERFEN USA LLCBase award · PIID 36C24126N0916
    Action+$14K
    Award net obligations$14K

VA in-vitro diagnostic substance manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top VA in-vitro diagnostic substance manufacturing contractors?

In the 12 months through September 10, 2026, BIOMERIEUX INC, CEPHEID, and ROCHE DIAGNOSTICS CORPORATION were the leading VA in-vitro diagnostic substance manufacturing prime contractors by positive obligations.

  1. #1

    BIOMERIEUX INC

    $29,249,931 in positive obligations

  2. #2

    CEPHEID

    $23,887,258 in positive obligations

  3. #3

    ROCHE DIAGNOSTICS CORPORATION

    $13,227,216 in positive obligations

Rankings use reported USAspending award data.

Did VA contract obligations decrease in the in-vitro diagnostic substance manufacturing market?

Yes. Measured by net prime contract obligations, reported VA activity in the in-vitro diagnostic substance manufacturing market decreased 8.3% from $116,074,022 in the preceding 12 months to $106,480,227 in the 12 months through September 10, 2026.

Latest 12 months
$106,480,227
Net prime contract obligations
Preceding 12 months
$116,074,022
Net prime contract obligations
Change
−8.3%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent VA contract award activity was reported in the in-vitro diagnostic substance manufacturing market?

Recent VA contract award activity reported in the in-vitro diagnostic substance manufacturing market included actions for ABBOTT MOLECULAR INC., CEPHEID, and FISHER SCIENTIFIC COMPANY L.L.C. during the 12 months through September 10, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for VA contracts under NAICS 325413?

From September 11, 2025 through September 10, 2026, VA reported 720 positive-obligation awards for in-vitro diagnostic substance manufacturing under NAICS 325413. The leading award type was delivery order. The leading reported procedure was simplified acquisition.

Positive-obligation awards
720
Leading reported procedure
Simplified Acquisition
35.3% of positive obligations
Leading award type
Delivery Order
43.4% of positive obligations
Full and open
26.5%
of positive obligations
Reported parent IDV
77.9%
of positive obligations

Percentages use positive obligations as the denominator.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology